fbpx
  • About us
  • Advertise
  • Contact
  • Nominate
  • Client’s Voice
  • Login
  • Register
📖 Magazine
The Global Economics
  • Home
  • Banking
  • Non Banking
  • Markets
  • Infrastructure
  • Lifestyle
  • FeatureNew
  • Awards
No Result
View All Result
  • Home
  • Banking
  • Non Banking
  • Markets
  • Infrastructure
  • Lifestyle
  • FeatureNew
  • Awards
No Result
View All Result
The Global Economics
No Result
View All Result
Home Infrastructure Healthcare

Marksans Pharma stock swells 18% as the board considers share buyback

The board of Marksans Pharma will meet on July 8 to consider the proposal for buyback

Ritu M R by Ritu M R
July 6, 2022
in Healthcare, Brokerage, The Global Economics, Top Stories
Reading Time: 2 mins read
0
Marksans Pharma stock swells 18% as the board considers share buyback

Marksans Pharma stock swells 18% as the board considers share buyback

27
SHARES
149
VIEWS
FacebookTwitterRedditWhatsAppLinkedInShare Link

Marksans Pharma shares soared 18% in early deals on Tuesday after the pharma company unveiled to consider the proposal for the buyback of fully paid-up equity shares of the company. In an exchange filing, the Mumbai-headquartered global pharmaceutical company says its board will meet on July 8 to consider a share buyback proposal. The firm, however, didn’t divulge the specifics involving the arrangement. As a result, Marksans Pharma stock climbed 18% to INR 51 (USD 0.64) against the previous closing of INR 43.20 (USD 0.55) on the Bombay Stock Exchange (BSE). Shares of Marksans Pharma opened with a gain of 11.57 per cent at INR 48.20 (USD 0.61) on Tuesday.

The stock has increased after two days of consecutive drops. As a result, the firm’s market capitalisation rose to INR 2,038.4 crore (USD 257.2 million) in the current session on BSE.

A total of 8.87 lakh shares of the firm changed hands, amounting to a turnover of INR 4.35 crore (USD 0.55 million) over the counter on the BSE compared to a two-week average of 0.74 lakh stocks by 12:30 PM. In comparison, the BSE benchmark Sensex was trading 607 points higher at 53,842 levels.

The stock has lost 44 per cent in a year and fallen 18.7 per cent in 2022. However, in a month, the stock has climbed 9 per cent. The share moved to a 52-week high of Rs 93.50 and a 52-week low of Rs 38.70 on July 6 2021, and June 20 2022, respectively.

A meeting of the board of directors of Marksans Pharma is scheduled to be held on Friday, July 8 2022, to consider the proposal for a buyback of fully paid equity shares of the company. The firm is striving to buy back an aggregate of the company’s paid-up equity share capital and free reserves as per the board’s decision, the pharma company said in a press release.

About Marksans Pharma Limited

Marksans Pharma Limited is a global pharmaceutical company headquartered in Mumbai, India. Marksans has subsidiaries in the US, the UK, and Australia, with proprietary marketing networks in these countries. The company has manufacturing units in India, the UK and the US and a research and development centre in Mumbai. The firm was integrated in 2001 as a holding of Glenmark Pharmaceuticals Ltd. In 2003, it spun off into a separate entity, focussing on the research, manufacturing, and marketing of generic pharmaceutical products.

Their key focus areas lie in the OTC and prescription drugs with wide-ranging applications across fields like Oncology, Cardiovascular, Gastroenterology, Antibiotics, Antidiabetic, Pain Management, and Gynaecology.

In April, the company acquired a 100% stake in Access Healthcare for Medical Products LLC, a Dubai-based front-marketing and promotion company. The investors of Access Healthcare will receive a cash consideration of AED 13 million (USD 3.54 million) on the closure of the transaction, which is subject to regulatory approvals.

Access Healthcare for Medical Products provides pharmaceutical companies with innovative marketing and sales solutions in the MENA (the Middle East and North Africa) region. The company provisions these products in the UAE and other neighbouring countries.

Via: Short URL
Tags: Glenmark Pharmaceuticals Ltd.indiaMarksans Pharma Limitedmumbaistocks
Ritu M R

Ritu M R

Ritu is a professional who aims at writing informative and engaging articles that appeal to the readers.

Related Posts

Sri Lanka: IMF approves $3 billion bailout for a crisis-stricken economy
Economy

Sri Lanka: IMF approves $3 billion bailout for a crisis-stricken economy

by Riya Thomas
March 21, 2023
First Republic Shares Plummet Amid Liquidity Fears
Banking

First Republic Shares Plummet Amid Liquidity Fears

by Anuj Singh
March 21, 2023
Amazon Announces Second Round of Layoffs, 9000 Roles to be Terminated
Technology

Amazon Announces Second Round of Layoffs, 9000 Roles to be Terminated

by Rahil Adnan
March 21, 2023
UEM Edgenta Paves the Way for Non-Clinical Tech Companies To Improve Healthcare Services
Exclusive Coverage

UEM Edgenta Paves the Way for Non-Clinical Tech Companies To Improve Healthcare Services

by The Global Economics
March 21, 2023
Saudi Real Estate Refinance Company (SRC) mulls its largest refining deal worth $1.3bn with Alrajhi
Islamic

Saudi Real Estate Refinance Company (SRC) mulls its largest refining deal worth $1.3bn with Alrajhi

by Riya Thomas
March 20, 2023
Previous
Next
Facebook Twitter Instagram Youtube LinkedIn Soundcloud
The Global Economics

The Global Economics Limited is a UK based financial publication and a quarterly business magazine giving thoughtful insights into the financial sectors on various industries across the world. Our highlight is the prestigious country specific Annual Global Economics awards program where the best performers in various financial sectors are identified worldwide and honoured.

DMCA.com Protection Status

  • Privacy
  • Legal
  • Terms of Use
  • Client’s Voice
  • Server Status

norton verified - the global economics

Latest Posts

First Republic Shares Plummet Amid Liquidity Fears

First Republic Shares Plummet Amid Liquidity Fears

March 21, 2023
Sri Lanka: IMF approves $3 billion bailout for a crisis-stricken economy

Sri Lanka: IMF approves $3 billion bailout for a crisis-stricken economy

March 21, 2023
Amazon Announces Second Round of Layoffs, 9000 Roles to be Terminated

Amazon Announces Second Round of Layoffs, 9000 Roles to be Terminated

March 21, 2023
Download The Global Economics PWA to your mobile or Desktop
PWA App Download
Download The Global Economics Android App to your mobile or Desktop
Android App
Download The Global Economics IOS App to your mobile or Desktop
IOS App

All Rights Reserved © 2020 | 🇬🇧 The Global Economics, Business Finance Publication - www.theglobaleconomics.uk 🌏

No Result
View All Result
  • About us
  • Awards
  • Magazine
  • Client’s Voice
  • Exclusive Coverage
  • Nominate
  • Login
  • Sign Up

All Rights Reserved © 2020 | 🇬🇧 The Global Economics, Business Finance Publication - www.theglobaleconomics.uk 🌏

Welcome Back!

Sign In with Facebook
Sign In with Linked In
OR

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Sign Up with Facebook
Sign Up with Linked In
OR

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
-
00:00
00:00

Queue

Update Required Flash plugin
-
00:00
00:00
Go to mobile version